Metraipolis › archive › dc_5985528a855f
Adjuvant capecitabine in women with triple-negative breast cancer with residual disease after carboplatin-containing neoadjuvant chemotherapy — Europe PMC PMID:41910838
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41910838
- DOI
- 10.1007/s10549-[numero omesso]-x
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-03T16:41:02.140Z
- SHA-256 of the archived text
14324f499dd47f18cb2a833ca31a26ddef58d8dd2686403f2cd5a6ac9bd93169- Stable URL of this page
https://metraipolis.com/documento/dc_5985528a855f
How to cite
Adjuvant capecitabine in women with triple-negative breast cancer with residual disease after carboplatin-containing neoadjuvant chemotherapy — Europe PMC PMID:41910838 — Europe PMC (en), https://europepmc.org/article/MED/41910838 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5985528a855f (Metraipolis archive dc_5985528a855f, sha256 14324f499dd47f18cb2a833ca31a26ddef58d8dd2686403f2cd5a6ac9bd93169)
BibTeX
@misc{dc5985528a855f,
title = {Adjuvant capecitabine in women with triple-negative breast cancer with residual disease after carboplatin-containing neoadjuvant chemotherapy — Europe PMC PMID:41910838},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41910838},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5985528a855f; sha256 14324f499dd47f18cb2a833ca31a26ddef58d8dd2686403f2cd5a6ac9bd93169},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41910838. Agents can read the archived copy with the MCP tool read_document.